RESUMO
Despite its endemic status in the Middle East, key knowledge gaps persist regarding the prevalence, transmission rate, and geographical distribution of both human and livestock brucellosis in Jordan. This study aimed to investigate the seroprevalence of human and livestock brucellosis as well as the incidence of brucellosis in humans in Jordan. A total of 500 human participants (202 exposed and 296 unexposed to livestock) were enrolled in the study. Sampling was conducted at baseline and 1.5 years later. Additionally, a total of 700 livestock were sampled, comprising 20 animals per taxa (camels, cattle, sheep, goats) per site, at both baseline (N = 350) and the 1.5-year follow-up (N = 350). Human participants were longitudinally followed, whereas livestock sampling was conducted opportunistically. Blood samples obtained from both humans and livestock at baseline and follow-up were tested for Brucella spp. serum antibodies using the Rose Bengal test (RBT) and complement fixation test (CFT). The overall seroprevalence of brucellosis in humans at baseline was 3.4 % (95 % CI: 2.0-5.4). Positive test results in humans were detected from all five sites with no significant regional variation observed. Seroprevalence was higher in individuals regularly exposed to livestock (6.1 %; 95 % CI: 3.5-9.9) compared to those not regularly exposed (0.80 %; 95 % CI: 0.10-2.9). Incidence of human brucellosis was 924 seropositives per 100,000 person-years, with all incident seropositives occurring in the livestock-exposed cohort. In livestock, the overall seroprevalence of brucellosis was 5.4 % (95 % CI: 3.5-8.3) at baseline compared to 2.6 % (95 % CI: 1.4-4.8) at follow-up. Seropositive livestock were detected at all sites apart from Al-Zarqa, and in all species apart from camels. In conclusion: Brucellosis burden was higher among humans regularly exposed to livestock, re-emphasizing the need for disease control in livestock populations to prevent primary infection in humans.
RESUMO
BACKGROUND: Zoonotic diseases constitute a threat to humans and animals. The Middle East Region is a hotspot for such a threat; given its geographic location under migratory birds' flight paths, mass gatherings, political conflicts, and refugee crises. Thus, prioritizing zoonotic diseases of national significance is critical for preventing and controlling such threats and optimizing limited resources. Using a multi-sectoral One Health (OH) approach, this study aimed at prioritizing zoonotic diseases of national significance to Jordan and identifying future recommendations and action plans. METHODS: Zoonotic diseases of national significance to Jordan were initially identified (n = 27 diseases). In December 2019, national staff from governmental and non-state sectors were invited to develop ranking criteria, including questions and answers choices, and to weigh each criterion. Then, the national staff were asked to assess zoonotic diseases' priority using the developed criteria and provide recommendations and action plans to strengthen multi-sectoral collaboration. RESULTS: Seven zoonotic diseases were identified as being of great significance. Rabies was ranked as the number one priority disease, followed by middle east respiratory syndrome, avian influenza, brucellosis, leishmaniasis, rickettsiosis, and salmonellosis. The highest weighted criteria used to rank diseases were disease severity, outbreaks profile, and potential human-to-human transmission. Establishing a one-health platform, surveillance, laboratory, preparedness planning, outbreak response, and workforce were suggested as recommendations for approaching the priority diseases. Respondents identified data sharing, coordination, event-based surveillance, and effective communication channels as vital areas to enhance prevention and control strategies, conduct joint outbreak investigations, and improve multi-sectoral collaboration. CONCLUSIONS: This study represents the first attempt to prioritize zoonotic diseases of national significance in Jordan using the OH approach and a semi-qualitative, transparent, and comparative method. Study results can be used as a decision-making guide for policymakers and stakeholders and a cornerstone for combating zoonotic disease threats.
RESUMO
To generate baseline information to help better understand the antibody kinetics and nasal shedding dynamics of MERS-CoV in camels in Jordan, a longitudinal surveillance study was conducted in two phases; phase 1 was between December, 2018 and January, 2019 and phase 2 between August and December 2020. In each phase, two camel herds were studied. These herds were located in Al-azraq and in Al-ramtha area and were named Al-azraq and Al-ramtha herds, respectively. The same camel herd of Al-zarqa area was sampled in both phases while two different camel herds, one in each phase, were sampled in Al-ramtha area. Blood and nasal swabs were collected from same selected animals in all visits to each herd in both phases. Additionally, nasal swabs and retropharyngeal lymph node tissue samples were collected from sixty-one camels slaughtered at Al-ramtha abattoir during phase 2 to enhance virus isolation opportunities and phylogenetic analysis. All sampled animals from Al-azraq camel herd were either borderline or seropositive on spike 1 based ELISA assay and negative on quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) in both phases. In Al-ramtha camel herds, an unsteady pattern prevailed in animals' seropositivity in both phases and viral RNA was detected in all animals in the end of phase 1 and in one animal during phase 2. For the seroconversion, anti-MERS-CoV spike 1 antibodies were detected in two animals in phase 1 in the first collection only. While, in phase 2, intermittent seroconversion pattern was observed in several samples over time of collections that ended with all animals became seropositive in the last collection (after nineteen days from viral RNA detection). In addition, viral RNA was detected in nasal swabs of 3 slaughtered camels. Phylogenetic analysis of a partial fragment of spike 1 gene sequences of all MERS-CoV isolates clustered together with clade B of MERS-CoV. This cluster contains all MERS-CoV sequences obtained either from camels or human sources in the Arabian Peninsula indicating the continuous circulation of this clade also in Jordan.
RESUMO
Middle East respiratory syndrome-related coronavirus (MERS-CoV) is a persistent zoonotic pathogen with frequent spillover from dromedary camels to humans in the Arabian Peninsula, resulting in limited outbreaks of MERS with a high case-fatality rate. Full genome sequence data from camel-derived MERS-CoV variants show diverse lineages circulating in domestic camels with frequent recombination. More than 90% of the available full MERS-CoV genome sequences derived from camels are from just two countries, the Kingdom of Saudi Arabia (KSA) and United Arab Emirates (UAE). In this study, we employ a novel method to amplify and sequence the partial MERS-CoV genome with high sensitivity from nasal swabs of infected camels. We recovered more than 99% of the MERS-CoV genome from field-collected samples with greater than 500 TCID50 equivalent per nasal swab from camel herds sampled in Jordan in May 2016. Our subsequent analyses of 14 camel-derived MERS-CoV genomes show a striking lack of genetic diversity circulating in Jordan camels relative to MERS-CoV genome sequences derived from large camel markets in KSA and UAE. The low genetic diversity detected in Jordan camels during our study is consistent with a lack of endemic circulation in these camel herds and reflective of data from MERS outbreaks in humans dominated by nosocomial transmission following a single introduction as reported during the 2015 MERS outbreak in South Korea. Our data suggest transmission of MERS-CoV among two camel herds in Jordan in 2016 following a single introduction event.
Assuntos
Camelus/virologia , Infecções por Coronavirus/veterinária , Variação Genética , Coronavírus da Síndrome Respiratória do Oriente Médio/genética , Zoonoses/virologia , Animais , Infecções por Coronavirus/epidemiologia , Infecções por Coronavirus/virologia , Genoma Viral , Jordânia/epidemiologia , Coronavírus da Síndrome Respiratória do Oriente Médio/classificação , Coronavírus da Síndrome Respiratória do Oriente Médio/isolamento & purificação , Filogenia , República da Coreia/epidemiologia , Arábia Saudita/epidemiologia , Emirados Árabes Unidos/epidemiologia , Zoonoses/epidemiologiaRESUMO
AIMS: The objectives of this study were to determine the prevalence and associated risk factors of bluetongue virus (BTV) in sheep and bovine ephemeral fever virus (BEFV) in dairy cattle in Jordan. MATERIALS AND METHODS: A simple randomized study was designed to collect 600 serum samples from sheep and 300 serum samples from dairy cattle located in the Northwestern parts of Jordan. In addition, data regarding farm management were collected using a pre-tested questionnaire through personal interview to determine potential risk factors. The seroprevalences of BEF and BTVs were determined using serum neutralization test and BTV group-specific competitive enzyme-linked immunosorbent assay, respectively. RESULTS: The overall seroprevalence of neutralizing antibodies against BEFV in dairy cattle was 45.37%. The overall seroprevalence of BTV group-specific antibodies in sheep was 47.8% (54% true seroprevalence). Logistic regression analysis identified geographic location (Irbid) (odds ratio [OR]=1.0; confidence interval [CI]=0.5-2.1), no use of disinfectants on the farm (OR=1.0; CI=0.05-0.1), and lack of veterinary services (OR=10; CI=3.5-13.2) as risk factors associated with high seropositivity against BTV in sheep. Geographic location (Jarash) (OR=3; CI=1.0-5.5), age of the animal (1-2 years of age (OR=1; CI=0.3-1.9), and lack of veterinary services (OR=9; CI=4-11) were identified as risk factors associated with high seroprevalence against BEFV in dairy cattle. CONCLUSION: Results of this study indicate that BEFV in dairy cattle and BTV in sheep are endemic in Northwestern regions of Jordan. Implementation of appropriate control measures is, therefore, required to reduce the adverse effects of these diseases on animal health and productivity.
RESUMO
Prevalence of Middle East respiratory syndrome coronavirus (MERS-CoV) was determined in 45 dromedary camels from two geographically separated herds in Jordan. Virus shedding was only detected in swabs obtained from the respiratory tract and primarily observed in camels younger than 3 years. MERS-CoV seroprevalence increased with age of camels. Bovine and sheep sera were seronegative. Phylogenetic analysis of partial S2 clustered the Jordanian MERS-CoV strains with contemporary MERS-CoV strains associated with nosocomial outbreaks.